SGMT 8-K 2026-11-12

Sagimet Biosciences Inc. (SGMT) 8-K dated 2026-11-12 — accession 0001193125-26-457000.

Sagimet Biosciences Inc. (SGMT) is a biotechnology company listed on NASDAQ.

SGMT: Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Pr…

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.

Not investment advice. The SGMT SEC hub lists recent forms. The stock page is the research view.